A5036096798- Bladder and Urothelial Cancer Treatments
- Renal cell carcinoma treatment
- Urinary and Genital Oncology Studies
- Multiple and Secondary Primary Cancers
- Pelvic floor disorders treatments
- Urinary Tract Infections Management
- Cancer Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Diabetes Management and Research
- Neurological and metabolic disorders
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Cancer Immunotherapy and Biomarkers
- Renal and related cancers
- Glioma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Economic and Financial Impacts of Cancer
- Urinary Bladder and Prostate Research
Tsuchiura Kyodo General Hospital
2024-2025
Tokyo Medical and Dental University
2024
Introduction Overactive bladder (OAB) is a condition characterised by urinary urgency, often accompanied frequency and nocturia. Antimuscarinics β3 receptor agonists are first-line therapies that improve symptoms the quality of life. For insufficient antimuscarinic response, options include dose increase, switching medications or combination therapy. However, evidence for these strategies, especially combinations with vibegron, limited needs further study. Methods analysis The study designed...
To evaluate the clinical characteristics of oligometastatic disease (OMD) in metastatic urothelial carcinoma (mUC) with visceral metastases when classified into synchronous and metachronous metastases.
Introduction Hypoglycemia occasionally develops after the resection of pheochromocytoma due to decreased catecholamine secretion. The unique glucose metabolism in dialysis patients may potentially affect postoperative hypoglycemia, although few reports have focused on this issue. Case presentation A 47‐year‐old woman who had chronic renal failure under hemodialysis was diagnosed with right and underwent an adrenalectomy. Three hours surgery, she experienced symptomatic which repeated until...
You have accessJournal of UrologyCME1 Apr 2023MP41-04 ASSOCIATION OF ELEVATED C-REACTIVE PROTEIN WITH WORSENED OUTCOMES IN DIFFERENT HISTOLOGIES RENAL CORTICAL TUMORS: ANALYSIS THE INMARC REGISTRY Cesare Saitta, Franklin Liu, Jonathan Afari, Margaret Meagher, Dattatraya Patil, Hajime Tanaka, Sohail Dhanji, Luke Wang, Benjamin Schmeusser, Dhruv Puri, Rachel Greenwald, Alexandra Medline, Fatima Kamal, Adil Ali, Shohei Fukuda, Masaki Kobayashi, Wei Chen, Bo Fan, Yusuke Aida, Yuya Maezawa,...
You have accessJournal of UrologyCME1 Apr 2023PD08-07 PREDICTIVE FACTORS FOR RECURRENCE AND OUTCOMES IN T1a RENAL CELL CARCINOMA: ANALYSIS OF THE INMARC (INTERNATIONAL MARKER CONSORTIUM CANCER) DATABASE Franklin Liu, Luke Wang, Sohail Dhanji, Margaret Meagher, Jonathan Afari, Cesare Saitta, Saeed Ghassemzadeh, Aastha Shah, Dhruv Puri, Mimi Nguyen, Kevin Hakimi, Benjamin Schmeusser, Rachel Greenwald, Alexandra Medline, Fatima Kamal, Adil Ali, Shohei Fukuda, Masaki Kobayashi, Wei Chen, Bo Fan,...
You have accessJournal of UrologyCME1 Apr 2023PD08-08 SHOULD ADJUVANT THERAPY BE CONSIDERED FOR POSITIVE SURGICAL MARGINS IN RENAL CELL CARCINOMA: A STAGE-BASED ANALYSIS OF IMPACT ON SURVIVAL OUTCOMES USING THE INMARC REGISTRY Margaret Meagher, Clara Cerrato, Dhruv Puri, Franklin Liu, Aastha Shah, Saeed Ghassemzadeh, Sohail Dhanji, Luke Wang, Dattatraya Patil, Kazutaka Saito, Yosuke Yasuda, Ryan Nasseri, Yasuhisa Fujii, Benjamin Schmeusser, Rachel Greenwald, Alexandra Medline, Fatima Kamal,...